These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 20432490)
1. The binding mode of side chain- and C3-modified epothilones to tubulin. Erdélyi M; Navarro-Vázquez A; Pfeiffer B; Kuzniewski CN; Felser A; Widmer T; Gertsch J; Pera B; Díaz JF; Altmann KH; Carlomagno T ChemMedChem; 2010 Jun; 5(6):911-20. PubMed ID: 20432490 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR of C12-C13-oxazoline derivatives of epothilone A. Pfeiffer B; Hauenstein K; Merz P; Gertsch J; Altmann KH Bioorg Med Chem Lett; 2009 Jul; 19(14):3760-3. PubMed ID: 19433359 [TBL] [Abstract][Full Text] [Related]
3. Computational study of binding of epothilone A to β-tubulin. Kamel K; Kolinski A Acta Biochim Pol; 2011; 58(2):255-60. PubMed ID: 21633729 [TBL] [Abstract][Full Text] [Related]
4. Epothilone analogues with benzimidazole and quinoline side chains: chemical synthesis, antiproliferative activity, and interactions with tubulin. Dietrich SA; Lindauer R; Stierlin C; Gertsch J; Matesanz R; Notararigo S; Díaz JF; Altmann KH Chemistry; 2009 Oct; 15(39):10144-57. PubMed ID: 19697384 [TBL] [Abstract][Full Text] [Related]
5. Conformational preferences of natural and C3-modified epothilones in aqueous solution. Erdélyi M; Pfeiffer B; Hauenstein K; Fohrer J; Gertsch J; Altmann KH; Carlomagno T J Med Chem; 2008 Mar; 51(5):1469-73. PubMed ID: 18271516 [TBL] [Abstract][Full Text] [Related]
6. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization. Feyen F; Cachoux F; Gertsch J; Wartmann M; Altmann KH Acc Chem Res; 2008 Jan; 41(1):21-31. PubMed ID: 18159935 [TBL] [Abstract][Full Text] [Related]
7. The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography. Nettles JH; Li H; Cornett B; Krahn JM; Snyder JP; Downing KH Science; 2004 Aug; 305(5685):866-9. PubMed ID: 15297674 [TBL] [Abstract][Full Text] [Related]
8. Structural insight into epothilones antitumor activity based on the conformational preferences and tubulin binding modes of epothilones A and B obtained from molecular dynamics simulations. Jiménez VA; Alderete JB; Navarrete KR J Biomol Struct Dyn; 2015; 33(4):789-803. PubMed ID: 24773261 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide. Gertsch J; Meier S; Müller M; Altmann KH Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273 [TBL] [Abstract][Full Text] [Related]
11. Making epothilones fluoresce: design, synthesis, and biological characterization of a fluorescent N12-aza-epothilone (azathilone). Gertsch J; Feyen F; Bützberger A; Gerber B; Pfeiffer B; Altmann KH Chembiochem; 2009 Oct; 10(15):2513-21. PubMed ID: 19760690 [TBL] [Abstract][Full Text] [Related]
12. Molecular modeling study on the tubulin-binding modes of epothilone derivatives: Insight into the structural basis for epothilones activity. Jiménez VA; Alderete JB; Navarrete KR Chem Biol Drug Des; 2017 Dec; 90(6):1247-1259. PubMed ID: 28632973 [TBL] [Abstract][Full Text] [Related]
13. High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design. Xiao Q; Xue T; Shuai W; Wu C; Zhang Z; Zhang T; Zeng S; Sun B; Wang Y Biochem Biophys Res Commun; 2021 Jan; 534():330-336. PubMed ID: 33272565 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of action of microtubule-stabilizing anticancer agents. Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720 [TBL] [Abstract][Full Text] [Related]
16. Interaction of epothilone analogs with the paclitaxel binding site: relationship between binding affinity, microtubule stabilization, and cytotoxicity. Buey RM; Díaz JF; Andreu JM; O'Brate A; Giannakakou P; Nicolaou KC; Sasmal PK; Ritzén A; Namoto K Chem Biol; 2004 Feb; 11(2):225-36. PubMed ID: 15123284 [TBL] [Abstract][Full Text] [Related]
17. The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies. Magnani M; Ortuso F; Soro S; Alcaro S; Tramontano A; Botta M FEBS J; 2006 Jul; 273(14):3301-10. PubMed ID: 16803461 [TBL] [Abstract][Full Text] [Related]
18. Much anticipated--the bioactive conformation of epothilone and its binding to tubulin. Heinz DW; Schubert WD; Höfle G Angew Chem Int Ed Engl; 2005 Feb; 44(9):1298-301. PubMed ID: 15714588 [No Abstract] [Full Text] [Related]
19. Preclinical discovery of ixabepilone, a highly active antineoplastic agent. Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795 [TBL] [Abstract][Full Text] [Related]
20. The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide. Sánchez-Pedregal VM; Kubicek K; Meiler J; Lyothier I; Paterson I; Carlomagno T Angew Chem Int Ed Engl; 2006 Nov; 45(44):7388-94. PubMed ID: 17036370 [No Abstract] [Full Text] [Related] [Next] [New Search]